{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "S. 2783"}, "official-title": {"#tail": "\n  ", "#text": "To establish a demonstration program requiring the utilization of Value-Based Insurance Design to\n\t\t\t demonstrate that reducing the copayments or coinsurance charged to\n\t\t\t Medicare beneficiaries for selected high-value prescription medications\n\t\t\t and clinical services can increase their utilization and ultimately\n\t\t\t improve clinical outcomes and lower health care expenditures."}, "session": {"#tail": "\n    ", "#text": "2d Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20140910", "#text": "September 10, 2014"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSFI00", "#text": "Committee on Finance"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Thune", "@name-id": "S303"}, "cosponsor": {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Ms. Stabenow", "@name-id": "S284"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "#text": "This Act may be cited as the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n      ", "quote": [{"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Value Based Insurance Design for Better Care Act of 2014", "@value": "Value Based Insurance Design for Better Care Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": " or the ", "#text": "\n          "}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "act", "#text": "VBID for Better Care Act of 2014", "@value": "VBID for Better Care Act of 2014", "@proposed": "true"}, "#text": "\n          "}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H3390C765DB9C47519E1706CBB0A194E2"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " makes the following findings:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "A growing body of evidence demonstrates that increases in patient-level financial barriers\n\t\t\t (including deductibles, copayments, and coinsurance) for high-value\n\t\t\t medical services (such as prescription medications, clinician visits,\n\t\t\t diagnostic tests, and procedures) systematically reduce their use. Savings\n\t\t\t attributable to cost-related decreased utilization of specific services\n\t\t\t may lead to an increase in total medical expenditures due to increased use\n\t\t\t of other related clinical services, such as hospitalizations and emergency\n\t\t\t room visits."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H32F5AC3177064215A9AF3766441F22BB", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Empirical research studies demonstrate that reductions in beneficiary out-of-pocket expenses for\n\t\t\t high-value prescription medications and clinical services can mitigate the\n\t\t\t adverse health and financial consequences attributable to cost-related\n\t\t\t decreased utilization of high-value services."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HB169A136E3D4478D9E099AAAD6C269EC", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Financial barriers to prescription medications and clinical services that are deemed to be\n\t\t\t high value should be reduced or eliminated to increase their use."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "HF524BD10F07E47EF854EB5F8DDE3A3AC", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "Value-Based Insurance Design is a methodology that adjusts patient out-of-pocket costs for\n\t\t\t prescription medications and clinical services according to the clinical\n\t\t\t value\u2014not exclusively the cost. Value-Based Insurance Design is based on\n\t\t\t the concept of clinical nuance that recognizes\u2014"}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "#text": "\n        ", "@id": "H507BFAB9DF2C415EA8107816CA562B1C", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "prescription medications and clinical services differ in the clinical benefit provided; and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H91D49DE532494546A1A4F65D39FEA98F", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "the clinical benefit derived from a specific prescription medication or clinical service depends on\n\t\t\t the clinical situation, the provider, and where the care is delivered."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H92B26DE010144AE88FFD3D15286EB6D7", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "quote": {"#tail": " copayment or coinsurance design for prescription medications and clinical services provided under\n\t\t\t the Medicare program does not recognize the well-established value\n\t\t\t differences in health outcomes produced by various medical interventions.", "#text": "one-size-fits-all"}, "#text": "The current "}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "HCD72611FBC924703AECB72966C354552", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "The establishment by Medicare of copayment and coinsurance requirements using Value-Based Insurance\n\t\t\t Design methodologies will improve patient-centered health outcomes,\n\t\t\t enhance personal responsibility, and afford a more efficient use of\n\t\t\t taxpayer dollars."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "HAF2A3089577C4F60A8EAC3312EA29DE0", "#text": "\n        "}], "#text": "\n      ", "@id": "H8818117DC65C43CCB0D1298777366CBC"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Demonstration program"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (in this section referred to as the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "part C\n\t\t\t of title XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII/pt:C"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u201321 et seq.", "@value": "usc/42/1395w\u201321/etseq"}, "@parsable-cite": "usc/42/1395w-21", "#text": "\n            ", "@legal-doc": "usc"}}, "quote": {"#tail": ") shall establish a 3-year demonstration program to test the use of value-based insurance design\n\t\t\t methodologies (as defined in subsection (c)(1)) under eligible Medicare\n\t\t\t Advantage plans offered by Medicare Advantage organizations under ", "#text": "Secretary"}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "#text": "\n        ", "@id": "H0D60ECC08D674BDF96FB584F8B008017"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Demonstration program design"}, "paragraph": [{"#tail": "\n        ", "@id": "H92FA036038724F38B072D26D3A20E088", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Selection of MA region and eligible Medicare Advantage plans"}, "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "select at least two MA regions (as defined in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") with respect to which to conduct the\n\t\t\t demonstration\n\t\t\t program under this section; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 1858(a)(2) of the Social Security Act", "@value": "Social Security Act/s:1858/ss:a/p:2"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t U.S.C. 1395w\u201327a(a)(2)", "@value": "usc/42/1395w\u201327a/a/2"}], "@entity-type": "law-citation", "#text": "\n                "}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HA4740EDDAEEA42D5A3F477E1C3C7C673", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "approve eligible Medicare Advantage plans to participate in such demonstration program."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HC67AAA979A824CEB9AC84F7BC3F777A8", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in at least one MA region selected under paragraph (1).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The demonstration program shall begin with respect to the first plan year beginning after the date\n\t\t\t on which at least two eligible Medicare Advantage plans have been approved\n\t\t\t by the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Start of demonstration"}, "#text": "\n          ", "@id": "H713990948D474F42B27704DC34E6A865"}, {"#tail": "\n      ", "@id": "H3C413525CB9E40C38AB5D96515A2F14A", "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Eligible Medicare Advantage plans"}, "text": {"#tail": "\n          ", "term": {"#tail": " means a Medicare Advantage plan under ", "#text": "eligible Medicare Advantage plan"}, "#text": "For purposes of this section, the term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " that meets the following requirements:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "part C of title XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII/pt:C"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 1395w\u201321 et seq.", "@value": "usc/42/1395w\u201321/etseq"}], "@entity-type": "law-citation", "#text": "\n              "}, "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "The plan is an MA regional plan (as defined in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") or MA local plan (as defined in paragraph (5) of such\n\t\t\t section) offered in the MA region selected under paragraph (1)(A).", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "paragraph (4) of section 1859(b) of such Act", "@value": "Social Security Act/s:1859/ss:b/p:4"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t U.S.C. 1395w\u201328(b)", "@value": "usc/42/1395w\u201328/b"}], "@entity-type": "law-citation", "#text": "\n                "}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "#text": "\n            ", "@id": "HE918A41F663B4666BC7C342DF9C601E4", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n            ", "#text": "The plan has\u2014"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "a quality rating under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " of 4 stars or\n\t\t\t higher based on the most recent data available for such year;", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1853(n)(4) of such Act", "@value": "Social Security Act/s:1853/ss:n/p:4"}, "@entity-type": "law-citation", "#text": "\n                  ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "uscode", "#text": "\n                  42 U.S.C. 1395w\u201323(n)(4)", "@value": "usc/42/1395w\u201323/n/4"}, "@parsable-cite": "usc/42/1395w-23", "#text": "\n                    ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "#text": "\n              ", "@id": "HC47F304229184FC3886CCF9693CAABD1", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "in the case of a specialized MA plan for special needs individuals, as defined in subsection\n\t\t\t (b)(6)(A) of ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", received a multi-year approval by the National\n\t\t\t Committee for Quality Assurance under subsection (f)(7) of such section;\n\t\t\t or", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 1859(b)(6)(A) of such Act", "@value": "Social Security Act/s:1859/ss:b/p:6/sp:A"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 1395w\u201328(b)(6)(A)", "@value": "usc/42/1395w\u201328/b/6/A"}], "@entity-type": "law-citation", "#text": "\n                  "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "#text": "\n              ", "@id": "H607D16B02F28497F84CAF2BE1BA052E0", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "at least 20 percent of the population to whom the plan is offered consists of subsidy eligible\n\t\t\t individuals (as defined in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ").", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1860D\u201314(a)(3)(A) of the Social\n\t\t\t Security Act", "@value": "Social Security Act/s:1860D\u201314/ss:a/p:3/sp:A"}, "@entity-type": "law-citation", "#text": "\n                  ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "uscode", "#text": "\n                  42 U.S.C. 1395w\u2013114(a)(3)(A)", "@value": "usc/42/1395w\u2013114/a/3/A"}, "@parsable-cite": "usc/42/1395w-114", "#text": "\n                    ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "H0A37A7228A0F468C8C7955B64B9402F9", "#text": "\n              "}], "#text": "\n            ", "@id": "H60C8E0B4E2EE4629AA5BA230B5958BA5"}]}], "#text": "\n        ", "@id": "H52871106CE7B4B299D6760A37B3AA90D"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Value-Based insurance design methodologies"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", for which\n\t\t\t copayments, coinsurance, or both should be reduced or eliminated because\n\t\t\t of the high value and effectiveness of such medications and services for\n\t\t\t specific chronic clinical conditions (as approved by the ", "@entity-type": "act", "#text": "title XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII"}, {"#tail": ").", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means a methodology for identifying specific prescription medications, and clinical services that\n\t\t\t are reimbursable under ", "#text": "value-based insurance design methodology"}, "#text": "For purposes of this section, the term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Definition"}, "#text": "\n          ", "@id": "H6A0B0F726E7C4A30A4B28AF2F531710B"}, {"#tail": "\n        ", "@id": "HBF08B845B02E42B1BAD2FBEA2BFF84C4", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Use of methodologies to reduce copayments and coinsurance"}, "text": {"#tail": "\n          ", "#text": "A Medicare Advantage organization offering an eligible Medicare Advantage plan selected to\n\t\t\t participate under the demonstration program, for each plan year for which\n\t\t\t the plan is so selected and using value-based insurance design\n\t\t\t methodologies\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") of MA eligible individuals (as\n\t\t\t defined in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "shall identify each prescription medication and clinical service covered under such plan for which\n\t\t\t the amount of the copayment or coinsurance should be reduced or\n\t\t\t eliminated, with respect to the management of specific chronic clinical\n\t\t\t conditions (as specified by the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") enrolled under such plans, for such plan year; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 1851(a)(3) of the Social Security Act", "@value": "Social Security Act/s:1851/ss:a/p:3"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 1395w\u201321(a)(3)", "@value": "usc/42/1395w\u201321/a/3"}], "@entity-type": "law-citation", "#text": "\n                "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H532D7E37FEA64E7FAACB2242D72E4055", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n            ", "#text": "may, for such plan year, reduce or eliminate copayments, coinsurance, or both for such prescription\n\t\t\t medication and clinical services so identified with respect to the\n\t\t\t management of such conditions of such individuals\u2014"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "if such reduction or elimination is evidence-based, for the purpose of encouraging such individuals\n\t\t\t in such plan to use such prescription medications and clinical services\n\t\t\t (such as preventive care, primary care, specialty visits, diagnostic\n\t\t\t tests, procedures, and durable medical equipment) with respect to such\n\t\t\t conditions; and"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H4F89B4DD95724FDA99CEA1EAA946870D", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "for the purpose of encouraging such individuals in such plan to use health care providers that such\n\t\t\t organization has identified with respect to such plan year."}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H47675DD07A19451AA66159685FEABD64", "#text": "\n              "}], "#text": "\n            ", "@id": "H2F0A9B8DE84E403FB2D95F860069801E"}]}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "In no case may any Medicare Advantage plan participating in the demonstration program increase, for\n\t\t\t any plan year for which the plan is so participating, the amount of\n\t\t\t copayments or coinsurance for any item or service covered under such plan\n\t\t\t for purposes of discouraging the use of such item or service.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Prohibition of increases of copayments and coinsurance"}, "#text": "\n          ", "@id": "HE5664C26379D4608A48B86EFE7907158"}], "#text": "\n        ", "@id": "H9103FDCBAD894D9DBBC4E9F13FDD1D9F"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Report on implementation"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " a report\n\t\t\t on the status of the implementation of the demonstration program.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than 1 year after the date on which the demonstration program under this section begins\n\t\t\t under subsection (b)(2), the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In general"}, "#text": "\n          ", "@id": "HAC23F89DEFA244238A160EAC19BD2456"}, {"#tail": "\n      ", "@id": "H5A81535331D74926955BA6E66BD05565", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Elements"}, "text": {"#tail": "\n          ", "#text": "The report required by paragraph (1) shall, with respect to eligible Medicare Advantage plans\n\t\t\t participating in the demonstration program for the first plan year of such\n\t\t\t program, include the following:"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "A list of each medication and service identified pursuant to subsection (c)(2)(A) for such plan\n\t\t\t with respect to such plan year."}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H45676A5E7CB54150AA7C9BAD45D7709D", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "For each such medication or service so identified, the amount of the copayment or coinsurance\n\t\t\t required under such plan with respect to such plan year for such\n\t\t\t medication or service and the amount of the reduction of such copayment or\n\t\t\t coinsurance from the previous plan year."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H59D37F62162B4D36B06FD29438F60E74", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "For each provider identified pursuant to subsection (c)(2)(B)(ii) for such plan with respect to\n\t\t\t such plan year, a statement of the amount of the copayment or coinsurance\n\t\t\t required under such plan with respect to such plan year and the amount of\n\t\t\t the reduction of such copayment or coinsurance from the previous plan\n\t\t\t year.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "HD944FC4F5BAE4B0E802CDBCAD636AA8B", "#text": "\n            "}]}], "#text": "\n        ", "@id": "H65C38DD1344A430A83A8D694AE3E54C6"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Review and assessment of utilization of value-Based insurance design methodologies"}, "paragraph": [{"#tail": "\n        ", "@id": "H4BA259779FF14758A3BF4CB96C0E9ECA", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In general"}, "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall enter into a contract or agreement with an independent, non-biased entity\n\t\t\t having expertise in value-based insurance design methodologies to review\n\t\t\t and assess the implementation of the demonstration program under this\n\t\t\t section. The review and assessment shall include the following:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "An assessment of the utilization of value-based insurance design methodologies by Medicare\n\t\t\t Advantage plans participating under such program."}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H42B5812A024B49BA96F737E82F970667", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "An analysis of whether reducing or eliminating the copayment or coinsurance for each medication and\n\t\t\t clinical service identified pursuant to subsection (c)(2)(A) resulted in\n\t\t\t increased adherence to medication regimens, increased service utilization,\n\t\t\t improvement in quality metrics, better health outcomes, and enhanced\n\t\t\t beneficiary experience."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HEFA6992939C045E8A0F611F1156A4EBB", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " participating in the demonstration program is less\n\t\t\t than costs to Medicare Advantage plans under such part that are not\n\t\t\t participating in the demonstration program.", "@entity-type": "act", "#text": "part C of title XVIII of\n\t\t\t the Social Security Act", "@value": "Social Security Act/t:XVIII/pt:C"}, "#text": "An analysis of the extent to which costs to Medicare Advantage plans under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "HBBDAC6C82FED490EABA0B2FC73B2F488", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "An analysis of whether reducing or eliminating the copayment or coinsurance for providers\n\t\t\t identified pursuant to subsection (c)(2)(B)(ii) resulted in improvement in\n\t\t\t quality metrics, better health outcomes, and enhanced beneficiary\n\t\t\t experience."}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "H0F1E2B8FE550456299033D62A0E064AD", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " participating in\n\t\t\t the demonstration program is less than costs to Medicare Advantage plans\n\t\t\t under such part that are not participating in the demonstration program.", "@entity-type": "act", "#text": "part C of title XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII/pt:C"}, "#text": "An analysis, for each provider so identified, the extent to which costs to Medicare Advantage plans\n\t\t\t under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "@id": "H8D83A4C3FC6748B8BD96BD1215C4C64A", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " considers appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Such other matters, as the "}, "enum": {"#tail": "\n            ", "#text": "(F)"}, "@id": "HC1504CF851BD4E588877F7E5B9C02803", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " a report on the review and assessment conducted by the\n\t\t\t entity under such paragraph in time for the inclusion of the results of\n\t\t\t such report in the report required by paragraph (3).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The contract or agreement entered into under paragraph (1) shall require such entity to submit to\n\t\t\t the "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Report"}, "#text": "\n          ", "@id": "HAC192A608AF44590BD2C6B18B54A8FAD"}, {"#tail": "\n      ", "@id": "H1C49C242DD774C93A7EB4D4B48EDA9C9", "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Report to Congress"}, "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " a report on the review and\n\t\t\t assessment of the demonstration program conducted under this subsection.\n\t\t\t The report shall include the following:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than 3 years after the date on which the demonstration program begins under subsection\n\t\t\t (b)(2), the "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "A description of the results of the review and assessment included in the report submitted pursuant\n\t\t\t to paragraph (2)."}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HD1031E3AB4D24977B67AA6101D792892", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " considers appropriate for enhancing the utilization of the\n\t\t\t methodologies applied under the demonstration program to all Medicare\n\t\t\t Advantage plans under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " so\n\t\t\t as to reduce copayments and coinsurance under such plans paid by Medicare\n\t\t\t beneficiaries for high-value prescription medications and clinical\n\t\t\t services for which coverage is provided under such plans and to otherwise\n\t\t\t improve the quality of health care provided under such plans.", "@entity-type": "act", "#text": "part C of title XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII/pt:C"}], "#text": "Such recommendations as the "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "#text": "\n            ", "@id": "HD16475623BED4FCA885441DF285B58F0", "@commented": "no"}]}], "#text": "\n        ", "@id": "HA128506339BC4CED946D518A7B981002"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall expand the demonstration program, pursuant to notice and comment rulemaking, to\n\t\t\t implement, on a permanent basis, the components of the demonstration\n\t\t\t program that are beneficial to Medicare beneficiaries and the Medicare\n\t\t\t program, unless the report under subsection (d) or (e)(3) contains an\n\t\t\t evaluation that the demonstration program\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(f)"}, "header": {"#tail": "\n        ", "#text": "Expansion of demonstration program"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to Medicare beneficiaries participating in\n\t\t\t the demonstration program; or", "@entity-type": "act", "#text": "title XVIII", "@value": "Social Security Act/t:XVIII"}, "#text": "increases expenditures under "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "HEF68EEF30B244E63B85853BA8E3A3846", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "decreases the quality of health care services furnished to such Medicare beneficiaries\n\t\t\t participating in the demonstration program."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "H359A8F7F5AE24E2C91C80CE61ACE5994", "@commented": "no"}], "#text": "\n        ", "@id": "HD03DEC573EB043E3A49456FE68571BC7", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may waive such provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "titles XI", "@value": "Social Security Act/t:XI"}, {"#tail": " as may be\n\t\t\t necessary to carry out the demonstration program under this section.", "@entity-type": "act", "#text": "XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(g)"}, "header": {"#tail": "\n        ", "#text": "Waiver authority"}, "#text": "\n        ", "@id": "H420068931C1C4153B0D299E57B29BF2C"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t provide for the transfer from the Federal Hospital Insurance Trust Fund\n\t\t\t under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", of such sums as may be necessary.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For purposes of carrying out the demonstration program under this section, the ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " and the\n\t\t\t Federal Supplementary Insurance Trust Fund under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1817 of the Social Security Act", "@value": "Social Security Act/s:1817"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395i", "@value": "usc/42/1395i"}, "@parsable-cite": "usc/42/1395i", "#text": "\n            ", "@legal-doc": "usc"}}, {"#tail": ", including the Medicare Prescription\n\t\t\t Drug Account in such Trust Fund, in such proportion as determined\n\t\t\t appropriate by the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1841 of the\n\t\t\t Social Security Act", "@value": "Social Security Act/s:1841"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395t", "@value": "usc/42/1395t"}, "@parsable-cite": "usc/42/1395t", "#text": "\n            ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n        ", "#text": "(h)"}, "header": {"#tail": "\n        ", "#text": "Implementation funding"}, "#text": "\n        ", "@id": "H85C849BADA94431DA79D02D6F74719BB"}], "#text": "\n      ", "@id": "H9F1EEA8F59224419B1A6922210510FDB"}], "#text": "\n    ", "@id": "H9EBCCA69EE264BA7B386CD2CA21C3566"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-09-10"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2783 IS: VBID for Better Care Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}